Type
Eule, Werner, Winsel, Iwainsky. [The pharmacokinetics of rifampicin in the intermittent treatment of patients with pulmonary tuberculosis. 2. The effect of rifampicin on the course of therapy for mycobacteriosis and non-tubercular infectious diseases]. Die Pharmazie. 1985;40(4):276-7.
Type
Sheriff. Another cause of facial nerve palsy. Postgraduate medicine. 1985;77(5):54.
Type
Pust, Campos-Outcalt. Leprosy in the United States. Risks, recognition, regimens, resources. Postgraduate medicine. 1985;77(5):151-5, 159.
Type
Singh, Gupta, MATHUR, Kumar, Chakraborty. Leucocyte migration inhibition response of Mycobacterium habana with sensitized animals and cells from leprosy patients. Indian journal of leprosy. 1985;57(2):273-7.
Type
Vries, Perry. Leprosy case detection rates by age, sex, and polar type under leprosy control conditions. American journal of epidemiology. 1985;121(3):403-13.
Type
Narayanan, Girdhar, Sengupta, Desikan. In vitro studies on dermal granulomas of human leprosy--cellular characteristics. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1985;53(1):39-44.
Type
Chiewsilp, Petchclai, Chirachariyavej, Ramasoota. Immunoglobulins in leprosy. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1985;53(1):28-32.
Type
Rook. Absence from sera from normal individuals or from rifampin-treated leprosy patients (THELEP trials) of antibody to rifamycin-protein or rifamycin-membrane conjugates. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1985;53(1):22-7.
Type
Jesudasan, Christian. Risk of paucibacillary leprosy patients released from control relapsing with multibacillary leprosy. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association [Internet]. 1985;53(1):19-21. Available from: http://ila.ilsl.br/pdfs/v53n1a03.pdf
Type
Cartel, Naudillon, Artus, Grosset. Hepatotoxicity of the daily combination of 5 mg/kg prothionamide + 10 mg/kg rifampin. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1985;53(1):15-8.